These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20586027)

  • 1. Prognostic value of membrane type 1 and 2 matrix metalloproteinase expression and gelatinase A activity in bladder cancer.
    Mohammad MA; Ismael NR; Shaarawy SM; El-Merzabani MM
    Int J Biol Markers; 2010; 25(2):69-74. PubMed ID: 20586027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
    Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
    J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of laminin-5 and membrane type 1-matrix metalloproteinase expression for cervical lymph node metastasis in T1 and T2 squamous cell carcinomas of the tongue and floor of the mouth.
    Kawano K; Yanagisawa S
    Head Neck; 2006 Jun; 28(6):525-33. PubMed ID: 16619276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
    Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
    J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
    Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.
    Morrison CJ; Overall CM
    J Biol Chem; 2006 Sep; 281(36):26528-39. PubMed ID: 16825197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue.
    Mohammad MA; Zeeneldin AA; Abd Elmageed ZY; Khalil EH; Mahdy SM; Sharada HM; Sharawy SK; Abdel-Wahab AH
    Mol Cell Biochem; 2012 Jul; 366(1-2):269-75. PubMed ID: 22527932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.
    Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B
    Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
    Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
    World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma.
    Ip YC; Cheung ST; Fan ST
    Mol Carcinog; 2007 Mar; 46(3):225-30. PubMed ID: 17219425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.
    Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T
    Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of matrix metalloproteinases type I expression and tumor front parameters in the presence of lymph node micrometastases in carcinoma of the larynx.
    Starska K; Łukomski M; Stasikowska O; Lewy-Trenda I
    Adv Med Sci; 2007; 52():169-73. PubMed ID: 18217412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma.
    Yoshizaki T; Maruyama Y; Sato H; Furukawa M
    Int J Cancer; 2001 Jan; 95(1):44-50. PubMed ID: 11241310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.